课题基金 / 基金详情

CHILDHOOD CANCER DATA INITIATIVE: CLINICAL TRIAL SPECIMEN MOLECULAR CHARACTERIZATION (CTSMC) PROGRAM

CHILDHOOD CANCER DATA INITIATIVE: CLINICAL TRIAL SPECIMEN MOLECULAR CHARACTERIZATION (CTSMC) PROGRAM
儿童癌症数据倡议:临床试验样本分子表征 (CTSMC) 计划
批准号:
10281333
负责人:
ETHAN DMITROVSKY
金额:
$399.75万
依托单位国家:
美国
项目类别:
财政年份:
2020
资助国家:
美国
项目状态:
未结题
起止时间:
2020-09-25 至 2025-09-24

项目摘要

项目成果

ETHAN DMITROVSKY的其他基金

相似基金

相关文献

中文摘要
翻译
临床试验标本分子表征(CTSMC)计划将进一步推动CCDI的目标,为参加由PBTC、PEP-CTN、儿科CITN和儿童肿瘤学组开展的NCI资助的临床试验的儿科和AYA患者提供标本的分子表征,用于开展试验和相关的相关科学研究。
英文摘要
The Clinical Trial Specimen Molecular Characterization (CTSMC) initiative will further the CCDI’s goals by providing molecular characterization of specimens from pediatric and AYA patients enrolled to NCI-funded clinical trials conducted by the PBTC, PEP-CTN, Pediatric CITN, and Children’s Oncology Group for use in the conduct of the trials and related correlative science studies.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
THIS IS A CPFF TO TO REFURBISH APA BUILDINGS (1033).
  • 批准号:
    10717450
  • 项目类别:
  • 资助金额:
    $571.96万
  • 财政年份:
    2022
  • 负责人:
    ETHAN DMITROVSKY
  • 依托单位:
VIRTUAL RESEARCH SUPPORT PILOT
  • 批准号:
    10717397
  • 项目类别:
  • 资助金额:
    $921.7万
  • 财政年份:
    2022
  • 负责人:
    ETHAN DMITROVSKY
  • 依托单位:
THIS IS A CPFF TO TO REFURBISH APA BUILDINGS 1034
  • 批准号:
    10717424
  • 项目类别:
  • 资助金额:
    $568.51万
  • 财政年份:
    2022
  • 负责人:
    ETHAN DMITROVSKY
  • 依托单位:
CONSOLIDATED FACILITIES REQUIREMENTS FOR FY22 TASK ORDER-A.
  • 批准号:
    10716600
  • 项目类别:
  • 资助金额:
    $227.35万
  • 财政年份:
    2022
  • 负责人:
    ETHAN DMITROVSKY
  • 依托单位:
海外基金